Literature DB >> 28685054

Single nucleotide variant sequencing errors in whole exome sequencing using the Ion Proton System.

Shiro Fujita1, Katsuhiro Masago1, Chiyuki Okuda1, Akito Hata1, Reiko Kaji1, Nobuyuki Katakami1, Yukio Hirata1.   

Abstract

Errors in sequencing are a major obstacle in the interpretation of next-generation sequencing (NGS) results. In the present study, sequencing errors identified from analysis of single nucleotide variants (SNVs) identified during exome sequencing of human germline DNA were studied using the Thermo Fisher Ion Proton System. Two consanguineous cases were selected for sequencing using the AmpliSeq Exome capture kit, and SNVs found in both cases were validated using Sanger sequencing. A total of 98 SNVs detected by NGS were randomly selected for further analysis. Nine of the analyzed SNVs were shown to be false positives when confirmed by Sanger sequencing. All but one SNV were considered to be homopolymer regions, mainly through the insertion or deletion of nucleotides. The remaining error was considered to be related to the primer. The present results revealed that the majority of the SNV sequencing errors originated from homopolymer insertion/deletion errors, which are commonly observed when using the Ion Torrent system.

Entities:  

Keywords:  Ion Proton; Ion Torrent; exome sequencing; next-generation sequencing; sequencing error; single nucleotide variants

Year:  2017        PMID: 28685054      PMCID: PMC5492560          DOI: 10.3892/br.2017.911

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


Introduction

Next-generation sequencing (NGS) has become a powerful and widely used clinical tool for the screening of mutations in hereditary disease and for the evaluation of driver and passenger mutations in cancer (1,2). Whole exome sequencing (WES), which targets protein coding regions of the genome, is the preferred option for the finding of new causative genetic variants in rare Mendelian disorders as well as the identification of genetic variants associated with individual types of cancer (3,4). The Ion Torrent NGS platform implements a semiconductor-based sequencing technology, the underlying principle of which is the non-optical detection of hydrogen ions released from the sequential addition of deoxynucleotides to a deoxyribonucleic acid (DNA) chain (5). The Ion Proton System, with 15 Gb output per run, and the AmpliSeq Exome kit, which performs target enrichment of the entire human exome by multiplex-polymerase chain reaction (PCR) amplification, enable researchers to examine exomes rapidly and with low cost. However, sequencing errors remain one of the main obstacles in the identification of causative genetic variants and/or mutations. Several patterns of sequencing error are recognized based on the rationale of the NGS system. Compared to the Illumina platforms, the Ion Proton platform has a high ratio of false positives in the identification of small insertion and deletion mutations (indel) but shows high accuracy in the identification of single nucleotide variant (SNV) (6–8). Considering that the vast majority of mutations (>90%) in human genome present as SNVs, and that clinical practice necessitates rapid sequencing at an acceptable cost for relatively few samples, the Ion Proton System is an attractive option for clinical exome evaluation. Therefore, information regarding SNV sequencing error (such as frequency and/or etiologic character) is important, as it has the potential to improve diagnostic accuracy and may avoid waste in the clinical decision process. In the present study, we describe the incidence and characteristics of sequencing errors during WES with the Ion Proton System, confirmed by Sanger sequencing.

Materials and methods

Overview

Two consanguineous patients were selected for WES. Identified SNVs were validated with Sanger sequencing.

Ethics statement

The present study was approved by the Institute of Biomedical Research and Innovation Hospitals Institutional Review Board. All the patients provided written informed consent. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.

Blood samples and DNA isolation

The blood samples used in the study were collected from the Institute of Biomedical Research and Innovation Hospital (Kobe, Japan). DNA was isolated from peripheral blood mononuclear cells using the QIAamp DNA Blood Mini kit (Qiagen, Hilden, Germany), as per the manufacturers instructions. We measured DNA concentration with NanoDrop Lite Spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA, USA).

Ion Torrent Proton library preparation and sequencing

An Ion Torrent adapter-ligated library was generated following the manufacturers protocol (Ion AmpliSeq™ Exome RDY kit PIv3, Rev. A.0; MAN0010084; Thermo Fisher Scientific, Inc.). Briefly, 100 ng high-quality genomic DNA was used to prepare the Ion AmpliSeq™ Exome capture library. Pooled amplicons were end-repaired, and Ion Torrent adapters and amplicons were ligated with DNA ligase. Following AMPure bead purification (Beckman Coulter, Inc., Brea, CA, USA), the concentration and size of the library were determined using the Applied Biosystems® StepOne™ Real-Time PCR system and Ion Library TaqMan® Quantitation kit (both from Thermo Fisher Scientific, Inc.). Sample emulsion PCR, emulsion breaking, and enrichment were performed using the Ion PI™ Hi-Q™ Chef 200 kit (Thermo Fisher Scientific, Inc.), according to the manufacturers instructions. An input concentration of one DNA template copy per ion sphere particles (ISPs) was added to the emulsion PCR master mix and the emulsion was generated using the Ion Chef™ System (Thermo Fisher Scientific, Inc.). Template-positive ISPs were enriched, sequencing was performed using Ion PI™ Chip kit v3 chips on the Ion Torrent Proton, and barcoding was performed using the Ion DNA Barcoding kit (Thermo Fisher Scientific, Inc.).

Variant calling

Data from the Proton runs were initially processed using Ion Torrent platform-specific pipeline software, Torrent Suite v4.0 (Thermo Fisher Scientific, Inc.) to generate sequence reads, trim adapter sequences, filter, and remove poor signal-profile reads. Initial variant calling from the Ion AmpliSeq™ sequencing data was generated using Torrent Suite with a plug-in ‘variant caller’ program. To eliminate erroneous base calling, three filtering steps were used to generate final variant calling. The first filter was set at an average depth of total coverage of >50, an each variant coverage of >15, and P<0.01. The second filter was employed by visually examining mutations using Integrative Genomics Viewer software (http://www.broadinstitute.org/igv) or CLC Genomics Workbench version 9.5.1 (Qiagen), as well as by filtering out possible strand-specific errors (i.e., a mutation was detected only in one, but not both, strands of DNA).

Results

A total of 26,260 SNVs were initially detected. We randomly selected 98 SNVs to be validated by Sanger sequencing. Of these, nine single nucleotide sequence errors were identified. A previous study identified primer-related sequencing errors in the Ion Torrent system (9). Of the 18 total primers (forward and reverse) of the exome capture kit we analyzed, one possible primer-related error was observed (Fig. 1).
Figure 1.

Possible primer-related sequencing error. The primer (shown in yellow underline) bound one of the non-specific sites, resulting in a sequencing error of G to T transversion mutation in PRICKLE3 (p. Cys251Ter, black arrowhead) located on chromosome X. This error was confirmed by Sanger sequencing.

The rest of the sequencing errors were unrelated to primers and were classified into three groups. Group 1 sequencing errors result from two homopolymer lesions, on both the 5′ and 3 sides, which cause a sequence error in the nucleotides of the junctional area (Fig. 2). NGS showed that loss of a nucleotide in one homopolymer area was accompanied by gain of a nucleotide in the other homopolymer area. The insertion locus was either at the immediate ends of the homopolymer regions (e.g., where sequence AAAAGGGG is reported as AAAAAGGG) or at a location a few nucleotides downstream of a homopolymer region (e.g., where AAAAACCGT becomes AAAAACACGT and the left-side C is masked, resulting in a sequencing error).
Figure 2.

Sequence errors categorized into Group 1. (A) Position of the variants, results of Sanger sequencing and sequence error of the Ion Torrent system are shown. (B) Representative mapped lesion of a C>G transversion in chromosome 17 position 2275720 (g.17:2275720 C>G hg19). Two homopolymer lesions (black and yellow underline) are directly linked in the hg19 reference sequence. A sequence error occurred in junctional area (black arrowhead).

Group 2 sequencing errors occur when a nucleotide lost from a homopolymer area is replaced by a nucleotide from another homopolymer within 10 nucleotides of the observed sequence error (Fig. 3). The neighboring homopolymer lesion is considered to be the main cause of this sequence error.
Figure 3.

Sequence errors categorized into Group 2. (A) Position of the variants, results of Sanger sequencing and sequence error of the Ion Torrent system are shown. (B) Representative mapped lesion of a G>T transversion in chromosome 4 position 76943088 (g.4:76943088 G>T hg19). One nucleotide loss of homopolymer area is occupied by another nucleotide (black arrowhead).

In Group 3, sequence error originates from the ‘elongation’ of a homopolymer lesion which may replace adjacent nucleotides (e.g., GGGCTA becomes GGGGTA). Insertion of two nucleotides, multiple homopolymers of which exist around the error, are observed in the sequence-error site. These two nucleotides mask the true nucleotide and a sequencing error occurs as a result (Fig. 4). Notably, all of the false-positive SNVs identified in the study are related to homopolymer regions.
Figure 4.

Sequence errors categorized into Group 3. (A) Position of the variants, results of Sanger sequencing and sequence error of the Ion Torrent system are shown. (B) Representative mapped lesion of an A>T transversion in chromosome 5 position 179994849 (g.5:179994849 A>T hg19). Two lines of nucleotide (black arrowheads), which seem to originate from the neighborhood homopolymer area of thymidine (shown with black line), are inserted. These nucleotides mask true sequence and induce sequence errors as a result.

Discussion

The Ion Torrent system uses semiconductor sequencing technology to detect the protons that are released as nucleotides incorporated during DNA synthesis (5). DNA fragments with specific adapter sequences are linked and then clonally amplified by emulsion PCR on the surface of 3-µm beads. These templated beads are loaded into proton-sensing microwells fabricated on a silicon wafer, and sequencing is primed from a specified location in the adapter sequence. A microwell is then flooded with a single species of deoxyribonucleotide triphosphate (dNTP). If the introduced dNTP is complementary to the leading template nucleotide, it is incorporated into the growing complementary strand (10). This causes the release of a proton, which triggers an ion-sensitive transistor sensor. If homopolymer repeats are present in the template sequence, multiple dNTP molecules may be incorporated in a single cycle, which leads to a corresponding number of released hydrogens and a proportionally higher electronic signal. This signal intensity is theoretically proportional to the number of released nucleotides; however, miscount of the intensity can occur, causing what is termed a homopolymer error. The majority of homopolymer errors occur at the immediate ends of homopolymer regions, where a sequence such as AAAAAAAA (an 8-nucleotide repeat) is reported as AAAAAAAAA (a 9-nucleotide repeat) or AAAAAAA (a 7-nucleotide repeat). These errors can also occur at a location several nucleotides downstream from a homopolymer region. In these cases, a sequence such as AAAAAATGC is read as AAAAAATAGC. Alternatively, a sequence of AAAAGTCG may be recognized as AAAAATCG or AAACGTCG. Sequencing errors remain a major challenge in the analysis of SNVs using NGS platforms. Our results indicated that SNVs located on junctional areas of two homopolymers (Group 1) require confirmation with Sanger sequencing. SNVs originating from homopolymer shortening or elongation (Groups 2 and 3, respectively) are possibly false positives, and confirmation is necessary. Several strategies are being investigated to avoid these homopolymer sequencing errors. The Hi-Q enzyme was introduced in 2014 to enhance SNV and indel performance on the Ion PGM system and later on the Ion Proton System. Internal tests indicated that the Ion PGM system used with the Hi-Q kit achieved a 43% reduction of indel errors in amplicon sequencing over the previous Ion PGM sequencing enzyme. Another strategy is the development of software for variant detection. Ion Reporter software is designed for analyzing sequence data obtained from the Ion Torrent system. This software is based on the algorithm of FreeBayes, a Bayesian genetic variant detector designed to find small polymorphisms (11). The present study revealed that the majority of the SNV sequencing errors originate from homopolymer insertion/deletion errors, are far more common in the Ion Torrent system than the competitor Illumina system. Even when the abovementioned measures are employed, the results obtained using the Ion Reporter System should be interpreted with caution.
  9 in total

1.  An integrated semiconductor device enabling non-optical genome sequencing.

Authors:  Jonathan M Rothberg; Wolfgang Hinz; Todd M Rearick; Jonathan Schultz; William Mileski; Mel Davey; John H Leamon; Kim Johnson; Mark J Milgrew; Matthew Edwards; Jeremy Hoon; Jan F Simons; David Marran; Jason W Myers; John F Davidson; Annika Branting; John R Nobile; Bernard P Puc; David Light; Travis A Clark; Martin Huber; Jeffrey T Branciforte; Isaac B Stoner; Simon E Cawley; Michael Lyons; Yutao Fu; Nils Homer; Marina Sedova; Xin Miao; Brian Reed; Jeffrey Sabina; Erika Feierstein; Michelle Schorn; Mohammad Alanjary; Eileen Dimalanta; Devin Dressman; Rachel Kasinskas; Tanya Sokolsky; Jacqueline A Fidanza; Eugeni Namsaraev; Kevin J McKernan; Alan Williams; G Thomas Roth; James Bustillo
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

2.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

3.  False positives in multiplex PCR-based next-generation sequencing have unique signatures.

Authors:  Chad M McCall; Stacy Mosier; Michele Thiess; Marija Debeljak; Aparna Pallavajjala; Katie Beierl; Kristen L Deak; Michael B Datto; Christopher D Gocke; Ming-Tseh Lin; James R Eshleman
Journal:  J Mol Diagn       Date:  2014-07-11       Impact factor: 5.568

4.  The new sequencer on the block: comparison of Life Technology's Proton sequencer to an Illumina HiSeq for whole-exome sequencing.

Authors:  Joseph F Boland; Charles C Chung; David Roberson; Jason Mitchell; Xijun Zhang; Kate M Im; Ji He; Stephen J Chanock; Meredith Yeager; Michael Dean
Journal:  Hum Genet       Date:  2013-06-12       Impact factor: 4.132

5.  Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome.

Authors:  Amélie Bonnefond; Emmanuelle Durand; Olivier Sand; Franck De Graeve; Sophie Gallina; Kanetee Busiah; Stéphane Lobbens; Albane Simon; Christine Bellanné-Chantelot; Louis Létourneau; Raphael Scharfmann; Jérôme Delplanque; Robert Sladek; Michel Polak; Martine Vaxillaire; Philippe Froguel
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 6.  Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls.

Authors:  Peter Horak; Stefan Fröhling; Hanno Glimm
Journal:  ESMO Open       Date:  2016-11-18

7.  Exome sequencing identifies the cause of a mendelian disorder.

Authors:  Sarah B Ng; Kati J Buckingham; Choli Lee; Abigail W Bigham; Holly K Tabor; Karin M Dent; Chad D Huff; Paul T Shannon; Ethylin Wang Jabs; Deborah A Nickerson; Jay Shendure; Michael J Bamshad
Journal:  Nat Genet       Date:  2009-11-13       Impact factor: 38.330

8.  Comparison and evaluation of two exome capture kits and sequencing platforms for variant calling.

Authors:  Guoqiang Zhang; Jianfeng Wang; Jin Yang; Wenjie Li; Yutian Deng; Jing Li; Jun Huang; Songnian Hu; Bing Zhang
Journal:  BMC Genomics       Date:  2015-08-05       Impact factor: 3.969

9.  Amplicon-based semiconductor sequencing of human exomes: performance evaluation and optimization strategies.

Authors:  E Damiati; G Borsani; Edoardo Giacopuzzi
Journal:  Hum Genet       Date:  2016-03-22       Impact factor: 4.132

  9 in total
  4 in total

1.  Exome sequencing of multiple-sclerosis patients and their unaffected first-degree relatives.

Authors:  Sheila Garcia-Rosa; Maria Galli de Amorim; Renan Valieris; Vanessa Daccach Marques; Julio Cesar Cetrulo Lorenzi; Vania Balardin Toller; Guilherme Sciascia do Olival; Wilson Araújo da Silva Júnior; Israel Tojal da Silva; Amilton Antunes Barreira; Diana Noronha Nunes; Emmanuel Dias-Neto
Journal:  BMC Res Notes       Date:  2017-12-12

2.  A novel knowledge-derived data potentizing method revealed unique liver cancer-associated genetic variants.

Authors:  Naznin Sultana; Mijanur Rahman; Sanat Myti; Jikrul Islam; Md G Mustafa; Kakon Nag
Journal:  Hum Genomics       Date:  2019-07-04       Impact factor: 4.639

3.  Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer.

Authors:  Shiro Fujita; Katsuhiro Masago
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

4.  NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology.

Authors:  Imogen A Wright; Kayla E Delaney; Mary Grace K Katusiime; Johannes C Botha; Susan Engelbrecht; Mary F Kearney; Gert U van Zyl
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.